Literature DB >> 26838740

Correlation of liver enzymes with diabetes and pre-diabetes in middle-aged rural population in China.

Jun-Hui Xie1, Qian Liu1, Yan Yang1, Zhe-Long Liu1, Shu-Hong Hu1, Xin-Rong Zhou1, Gang Yuan1, Mu-Xun Zhang1, Jing Tao1, Xue-Feng Yu2.   

Abstract

The survey aimed to explore the association of liver transaminases with the prevalence of type 2 diabetes mellitus (T2DM) and pre-diabetes (pre-DM) in the middle-aged rural population in China. A cross-sectional study was conducted in 10 800 middle-aged subjects who lived in rural area of central China. The 75-g oral glucose-tolerance test (OGTT) was performed. Participants were asked to complete physical examination and standard questionnaire. The serum liver transaminases (ALT and GGT), HbA1C and serum lipids were measured. In middle-aged rural population, the prevalence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), impaired fasting glucose combined with impaired glucose tolerance (IFG+IGT) and DM was 4.0%, 11.8%, 2.6% and 10.0%, respectively. Some measurements were higher in males than in females, such as waist hip ratio (WHR), blood pressure, fasting blood glucose (FBG), high density lipoprotein-cholesterol (HDL-C), and liver enzymes (ALT and GGT). Further, we found that elevated serum GGT and ALT levels were significantly positively correlated with the prevalence of DM, independent of central obesity, serum lipid and insulin resistance (IR) in both genders. However, the correlation of GGT and ALT with pre-DM was determined by genders and characteristics of liver enzymes. Higher serum GGT was indicative of IGT in both genders. The association of serum ALT with pre-DM was significant only in female IGT group. In conclusion, our present survey shows both serum GGT and ALT are positively associated with DM, independent of the cardiovascular risk factors in both genders.

Entities:  

Keywords:  alanine aminotransferase; live enzymes; pre-diabetes; type 2 diabetes mellitus; γ-glutamyltransferase

Mesh:

Substances:

Year:  2016        PMID: 26838740     DOI: 10.1007/s11596-016-1541-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

1.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

Authors:  Barbora Vozarova; Norbert Stefan; Robert S Lindsay; Aramesh Saremi; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

2.  Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

Authors:  P André; B Balkau; C Born; M A Charles; E Eschwège
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

Review 3.  Gamma glutamyl transferase.

Authors:  J B Whitfield
Journal:  Crit Rev Clin Lab Sci       Date:  2001-08       Impact factor: 6.250

4.  Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.

Authors:  Jiko Yamada; Hirofumi Tomiyama; Minoru Yambe; Yutaka Koji; Kohki Motobe; Kazuki Shiina; Yoshio Yamamoto; Akira Yamashina
Journal:  Atherosclerosis       Date:  2006-01-06       Impact factor: 5.162

5.  Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

Authors:  Monica Nannipieri; Clicerio Gonzales; Simona Baldi; Rosalinda Posadas; Ken Williams; Steven M Haffner; Michael P Stern; Ele Ferrannini
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

6.  Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.

Authors:  N Nakanishi; K Nishina; W Li; M Sato; K Suzuki; K Tatara
Journal:  J Intern Med       Date:  2003-09       Impact factor: 8.989

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

9.  Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

Authors:  Noriyuki Nakanishi; Kenji Suzuki; Kozo Tatara
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

10.  Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai.

Authors:  Rui Li; Wei Lu; Qing Wu Jiang; Yan Yun Li; Gen Ming Zhao; Liang Shi; Qun Di Yang; Ye Ruan; Junyi Jiang; Sheng Nian Zhang; Wang Hong Xu; Wei Jian Zhong
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

View more
  3 in total

1.  Is Acupuncture Effective for Improving Insulin Resistance? A Systematic Review and Meta-analysis.

Authors:  Ai-Qun Song; Yang-Pu Zhang; Rui Chen; Feng-Xia Liang
Journal:  Curr Med Sci       Date:  2018-12-07

2.  High Liver Enzyme Concentrations are Associated with Higher Glycemia, but not with Glycemic Variability, in Individuals without Diabetes Mellitus.

Authors:  Raymond Noordam; Debbie Vermond; Hermijntje Drenth; Carolien A Wijman; Abimbola A Akintola; Sabrina van der Kroef; Steffy W M Jansen; Neline C Huurman; Bianca A M Schutte; Marian Beekman; P Eline Slagboom; Simon P Mooijaart; Diana van Heemst
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-13       Impact factor: 5.555

3.  Association of liver enzymes levels with fasting plasma glucose levels in Southern China: a cross-sectional study.

Authors:  Ling-Ling Huang; Dong-Hui Guo; Hui-Yan Xu; Song-Tao Tang; Xiao Xiao Wang; Yong-Ping Jin; Peixi Wang
Journal:  BMJ Open       Date:  2019-10-18       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.